MEDCAP AB financials
MEDCAP AB
Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI:
549300NGO5XAJ6TL8719 ISIN: SE0009160872 Financial statements
(SEK, as reported — unscaled; 97 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 1.81B | SEK 1.59B |
| Other income | SEK 35.3M | SEK 16.4M |
| Employee benefits expense | SEK 464.9M | SEK 412.8M |
| Raw materials & consumables used | SEK 754.0M | SEK 663.8M |
| Operating profit (EBIT) | SEK 272.3M | SEK 227.5M |
| Net finance income / (cost) | -SEK 10.7M | -SEK 5.2M |
| Finance costs | SEK 19.0M | SEK 15.6M |
| Profit before tax | SEK 261.6M | SEK 222.3M |
| Income tax expense | SEK 52.3M | SEK 49.8M |
| Profit for the year | SEK 209.2M | SEK 172.5M |
| — attributable to owners | SEK 207.4M | SEK 172.2M |
| — attributable to NCI | SEK 1.9M | SEK 300.0K |
| Total comprehensive income | SEK 225.3M | SEK 165.0M |
| Per share | ||
| Basic EPS | SEK 14.00 | SEK 11.60 |
| Diluted EPS | SEK 14.00 | SEK 11.60 |
| Free cash flow / share | SEK 21.51 | SEK 13.82 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 360.0M | SEK 228.0M |
| Income taxes paid | SEK 73.6M | SEK 33.3M |
| Net cash from investing activities | -SEK 128.8M | -SEK 152.3M |
| Purchase of PP&E (capex) | SEK 41.7M | SEK 22.1M |
| Purchase of intangibles | SEK 24.5M | SEK 17.2M |
| Net cash from financing activities | -SEK 46.1M | -SEK 119.7M |
| Repayments of borrowings | SEK 67.0M | SEK 84.6M |
| Balance sheet | ||
| Total assets | SEK 1.99B | SEK 1.66B |
| Non-current assets | SEK 1.07B | SEK 897.0M |
| Property, plant & equipment | SEK 402.7M | SEK 243.9M |
| Right-of-use assets | SEK 274.8M | SEK 142.1M |
| Intangible assets & goodwill | SEK 667.1M | SEK 649.2M |
| Current assets | SEK 917.4M | SEK 765.2M |
| Inventories | SEK 268.9M | SEK 276.7M |
| Cash & equivalents | SEK 370.1M | SEK 188.2M |
| Total equity | SEK 1.29B | SEK 1.03B |
| — attributable to owners | SEK 1.28B | SEK 1.02B |
| Non-controlling interests | SEK 6.2M | SEK 4.2M |
| Non-current liabilities | SEK 371.6M | SEK 292.1M |
| Lease liabilities (non-current) | SEK 248.6M | SEK 120.2M |
| Current liabilities | SEK 331.5M | SEK 343.0M |
| Lease liabilities (current) | SEK 35.4M | SEK 27.0M |
| Deferred tax liabilities | SEK 62.1M | SEK 66.7M |
| Derived metrics | ||
| Free cash flow | SEK 318.3M | SEK 205.9M |
| Operating margin | 15.1% | 14.3% |
| Net margin | 11.6% | 10.9% |
| Return on equity | 16.2% | 16.8% |
| Cash conversion ratio | 1.72× | 1.32× |
| Capex coverage | 8.63× | 10.32× |
| Other reported items | ||
| Adjusted Weighted Average Shares | 14.8M | 14.9M |
| Adjustments For Decrease Increase In Inventories | SEK 42.3M | -SEK 47.2M |
| Adjustments For Decrease Increase In Trade and Other Receivables | SEK 44.1M | -SEK 8.3M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 115.4M | SEK 104.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | -SEK 14.7M | -SEK 13.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 288.3M | SEK 297.3M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 62.7M | SEK 113.1M |
| Changes In Inventories of Finished Goods and Work In Progress | SEK 9.3M | SEK 7.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | SEK 2.0M | SEK 300.0K |
| Comprehensive Income Attributable To Owners of Parent | SEK 223.3M | SEK 164.7M |
| Current Accrued Expenses and Other Current Liabilities | SEK 106.1M | SEK 99.3M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | SEK 25.2M | SEK 42.0M |
| Current Prepayments | SEK 41.5M | SEK 38.8M |
| Current Tax Assets Current | SEK 16.4M | SEK 9.3M |
| Current Tax Liabilities Current | SEK 42.1M | SEK 46.7M |
| Deferred Tax Assets | SEK 3.6M | SEK 3.4M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 115.4M | SEK 104.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | SEK 0.00 | — |
| Dividends Recognised As Distributions To Owners Per Share | SEK 0.00 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -SEK 3.2M | -SEK 4.1M |
| Equity and Liabilities | SEK 1.99B | SEK 1.66B |
| Finance Income | SEK 8.3M | SEK 10.4M |
| Increase Decrease In Cash and Cash Equivalents | SEK 185.2M | -SEK 43.9M |
| Increase Decrease Through Exercise of Options | — | SEK 1.8M |
| Intangible Assets Other Than Goodwill | SEK 304.8M | SEK 309.3M |
| Interest Paid Classified As Operating Activities | SEK 6.6M | SEK 8.5M |
| Interest Received Classified As Operating Activities | SEK 8.3M | SEK 6.6M |
| Issue of Equity | SEK 35.9M | — |
| Issued Capital | SEK 6.0M | SEK 5.9M |
| Miscellaneous Other Operating Expense | SEK 6.4M | SEK 10.6M |
| Noncontrolling Interest In Acquiree Recognised At Acquisition Date | — | SEK 1.6M |
| Noncurrent Provisions | SEK 4.7M | SEK 4.4M |
| Number of Shares Outstanding | 15.0M | 14.8M |
| Other Adjustments For Noncash Items | -SEK 27.4M | SEK 1.0M |
| Other Comprehensive Income | SEK 16.0M | -SEK 7.5M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | SEK 16.0M | -SEK 7.5M |
| Other Current Payables | SEK 49.9M | SEK 37.4M |
| Other Expense By Nature | SEK 233.6M | SEK 188.3M |
| Other Noncurrent Financial Liabilities | SEK 48.8M | SEK 72.0M |
| Other Noncurrent Liabilities | SEK 7.5M | SEK 28.8M |
| Other Noncurrent Receivables | SEK 600.0K | SEK 400.0K |
| Other Receivables | SEK 10.0M | SEK 15.3M |
| Other Work Performed By Entity and Capitalised | SEK 13.7M | SEK 10.7M |
| Payments To Acquire Or Redeem Entitys Shares | -SEK 35.9M | SEK 0 |
| Proceeds From Exercise of Options | SEK 0 | SEK 1.8M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | SEK 200.0K | SEK 100.0K |
| Reserve of Exchange Differences On Translation | SEK 28.4M | SEK 12.7M |
| Retained Earnings | SEK 783.6M | SEK 576.0M |
| Share Premium | SEK 464.0M | SEK 428.2M |
| Trade and Other Current Payables To Trade Suppliers | SEK 72.7M | SEK 90.6M |
| Trade Receivables | SEK 210.6M | SEK 237.0M |
| Weighted Average Shares | 14.8M | 14.8M |
Methodology
Every line item above is a fact tagged in MEDCAP AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.